Skip to main content
PMC home page
Oxidative Medicine and Cellular Longevity logoLink to Oxidative Medicine and Cellular Longevity
. 2018 Jan 31;2018:6717212. doi: 10.1155/2018/6717212

Hydrogen Sulfide Attenuates LPS-Induced Acute Kidney Injury by Inhibiting Inflammation and Oxidative Stress

Yuhong Chen 1,2, Sheng Jin 1, Xu Teng 1, Zhenjie Hu 2, Zhihong Zhang 1, Xuan Qiu 3, Danyang Tian 1, Yuming Wu 1,4,5,✉
PMCID: PMC5831990  PMID: 29636853

Abstract

In order to investigate the protective mechanism of hydrogen sulfide (H2S) in sepsis-associated acute kidney injury (SA-AKI), ten AKI patients and ten healthy controls were enrolled. In AKI patients, levels of creatinine (Cre), urea nitrogen (BUN), tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β), and myeloperoxidase (MPO) activity as well as concentrations of malondialdehyde (MDA) and hydrogen peroxide (H2O2) were significantly increased compared with those of controls. However, plasma level of H2S decreased and was linearly correlated with levels of Cre and BUN. After that, an AKI mouse model by intraperitoneal lipopolysaccharide (LPS) injection was constructed for in vivo study. In AKI mice, H2S levels decreased with the decline of 3-MST activity and expression; similar changes were observed in other indicators mentioned above. However, the protein expressions of TLR4, NLRP3, and caspase-1 in mice kidney tissues were significantly increased 6 h after LPS injection. NaHS could improve renal function and kidney histopathological changes, attenuate LPS-induced inflammation and oxidative stress, and inhibit expressions of TLR4, NLRP3, and caspase-1. Our study demonstrated that endogenous H2S is involved in the pathogenesis of SA-AKI, and exogenous H2S exerts protective effects against LPS-induced AKI by inhibiting inflammation and oxidative stress via the TLR4/NLRP3 signaling pathway.

1. Introduction

AKI is a clinical syndrome caused by various factors and characterized by a rapid decline in renal function. Sepsis is the most common cause of AKI (40%–50%) in critically ill patients, and the mortality of SA-AKI is as high as 70% [1, 2]. The pathogenesis of SA-AKI is complicated, including inflammation, coagulation cascade activation, oxidative stress, microcirculatory disturbance, renal hypoperfusion, and renal venous congestion [3, 4]. Despite the growing understanding of the pathophysiological mechanisms of AKI, the development of pharmacological treatments for AKI shows little progress.

LPS is a normal component of cell wall of most Gram-negative bacteria, which can trigger cytokine synthesis, secretion, and a subsequent inflammatory process. Previous studies have demonstrated that LPS is one of the most important causes of sepsis and is involved in the pathogenesis of SA-AKI, which may lead to “cytokine storm,” intensified oxidative stress, low blood pressure, renal hypoperfusion, and finally a gradual decline in renal function [5–7]. Toll-like receptors (TLRs) are the most important pattern-recognition receptors and play a key role in innate immunity. The major receptor for LPS is TLR4 [8, 9], which is activated after LPS binding, and induces downstream signaling cascades as well as expression of inflammatory cytokines [10]. Nucleotide-binding domain and leucine-rich repeat protein-3 (NLRP3) inflammasome is one of the most important members of the Nod-like receptor (NLR) family, including NLRP3, the adaptor protein ASC, and a cysteine protease caspase-1. Abderrazak et al. [11] have found that NLRP3 inflammasome participated in the inflammatory process and may be critical for the development of sepsis and AKI. Activation of NLRP3 inflammasome could promote the maturation and release of proinflammatory cytokines IL-1β and IL-18. Another study found that NLRP3 expression induced by LPS was dose- and time-dependent, but it failed to induce NLRP3 expression in cells in the absence of TLR4 [12].

H2S was considered to be toxic for a long time until endogenous H2S was discovered in the rat brain [13]. H2S is mainly synthesized from L-cysteine by two pyridoxal-5′-phosphate- (PLP-) dependent enzymes, namely, cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE), and one phosphate-independent enzyme, 3-mercaptopyruvate sulfurtransferase (3-MST) [14]. Recently, a new H2S-synthesis pathway from D-cysteine by 3-MST along with D-amino acid oxidase (DAO) was discovered; moreover, D-cysteine was shown to be significantly superior to L-cysteine, particularly in the kidney and cerebellum [15]. Numerous studies have shown that H2S might have a potential therapeutic effect on ischemia/reperfusion injury (IRI) in multiple organs and metabolic diseases by inhibiting inflammation and oxidative stress [16–21]. Huang et al. [16] have demonstrated that H2S could protect against high glucose-induced inflammation and apoptosis by inhibiting the TLR4/NF-κB pathway and NLRP3 activation in H9c2 cardiomyocytes. Zhang et al. [19] suggested that treatment with H2S could attenuate endotoxin-induced lung inflammation by inhibiting inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production. Shibuya et al. [15] have reported that administration of D-cysteine could increase the H2S level in kidney tissues and protect renal function from IRI. Ahmad et al. [20] and Han et al. [21] also demonstrated that exogenous H2S accelerates kidney repair after IRI by inhibiting oxidative stress and inflammation. Although various effects of H2S in disease have been discovered, the role of H2S in the inflammatory process of sepsis has been a matter of debate for a long time. Whether H2S protects renal function by regulating inflammation and oxidative stress in SA-AKI remains unclear.

The purpose of the trial was to examine the effect of H2S on renal function during sepsis and the underlying mechanisms of H2S in SA-AKI.

2. Materials and Methods

2.1. Patients and Blood Sample Collection

Ten patients with AKI (AKI group) were recruited from the ICU at the Fourth Hospital of Hebei Medical University in China from June 2016 to November 2016, and ten healthy donors (control group) were selected from the age-matched population. AKI is defined as an abrupt decrease in renal function (within 48 h) and diagnosed according to the definition of the Acute Dialysis Quality Initiative group [22]. All patients with AKI were infected with Gram-negative bacteria (covering 2 cases from Acinetobacter baumannii, 2 cases from Pseudomonas aeruginosa, 2 cases from Klebsiella, 3 cases from Escherichia coli, and 1 case from Clostridium difficile), and renal injury caused by renal and postrenal factors has been excluded. None of the patients had been treated with drugs that cause kidney damage before. The patients who are younger than 18 years old, pregnant, or with a history of chronic renal dysfunction were excluded. The general condition and medical history of all participants were recorded. Blood samples were prospectively obtained from each participant at admission; after centrifugation for 10 minutes at 4000 rpm, the supernatants were frozen at −80°C. Each patient provided written informed consent prior to the study. The protocol was approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University (Shijiazhuang, China) and performed in accordance with all applicable laws, regulations, and guidelines in China (including good clinical practice guidelines), which are relating protection of human subjects as volunteers. The study complied with the published regulations of the Declaration of Helsinki.

2.2. Drugs and Chemicals

LPS and NaHS were obtained from Sigma (Sigma–Aldrich, USA). NaHS was prepared 30 minutes before use. Detection kits for TNF-α and IL-1β levels were purchased from Xinbosheng Bioengineering (Shenzhen, China). Detection kits for MDA, H2O2, and MPO activities were obtained from Jiancheng BioEngineering (Nanjing, China). Dihydroethidium (DHE) was obtained from Beyotime Biotechnology (Shanghai, China) and, before use, dissolved in dimethyl sulfoxide (DMSO) to the desired concentration. Bicinchoninic acid (BCA) reagent was purchased from Generay Biotechnology (Shanghai, China).

2.3. Animals and Treatments

Male wild-type C57BL/6 J mice (8–10 weeks) were purchased from Vital River Laboratories (Beijing, China), subsequently housed and bred in standard conditions (12 h light/dark cycle) under constant temperature (22°C ± 2°C) and humidity (60%), and given free access to food and water.

After two weeks, 24 mice were divided into three groups randomly (n = 8): control, LPS, and LPS + NaHS (50 μmol/L) groups. The LPS and LPS + NaHS groups were i.p. injected with LPS (5 mg/kg); in the control group, mice received an equal volume of saline (i.p.). Three hours after LPS treatment, the LPS + NaHS group received NaHS (50 μmol/kg, i.p.); the LPS group were injected with an equal volume of saline (i.p.). The blood and kidney tissues of mice were collected 6 h after LPS treatment. Blood samples were immediately spun for 10 minutes at 4000 rpm and frozen at −80°C. The left kidney tissues were fixed with paraformaldehyde (4%), and the right kidney tissues were frozen at −80°C. All animal studies were carried out under the Guide for the Care and Use of Laboratory Animals (1985, NIH) after a review by the Ethics Committee for Laboratory Animals Care and Use of Hebei Medical University.

2.4. Histological Analysis

The kidney tissues were fixed with paraformaldehyde (4%), after 48 hours, paraffin-embedded and sectioned into 4 μm thick, and then processed for hematoxylin and eosin (H&E) staining and evaluated using a light microscope (Olympus BX40, Tokyo, Japan). Kidney histological changes were scored as the previous study described [23] and evaluated in a double-blind fashion. Kidney damage was estimated at 5 randomly selected fields in the outer medulla, and tubular injury was defined as cellular degeneration and vacuolization, reduction of brush border epithelium, tubular obstruction, and cast formation. According to the following criteria: 0 = normal; 1 = damage less than 25% of tubular area; 2 = damage between 25% and 50% of tubular area; 3 = damage between 50% and 75% of tubular area; and 4 = damage between 75% and 100% of tubular area.

2.5. Measurements of Cre and BUN Levels in Plasma

Plasma Cre and BUN levels in patients and mice were measured using an automatic biochemical analyzer (Cobas 6000, Roche, Switzerland).

2.6. Measurement of Inflammatory Cytokines in Plasma

The enzyme-linked immunosorbent assay (ELISA) kits were used to determine the plasma TNF-α and IL-1β levels in patients and mice.

2.7. Measurement of the MPO Activity and MDA and H2O2 Concentrations

The plasma of patients and kidney tissues of mice were collected as described above. MPO activity and MDA and H2O2 concentrations were measured with colorimetric detection kits.

2.8. Measurement of Reactive Oxygen Species (ROS) Level

ROS level in kidney tissues was measured by staining the fresh frozen sections with DHE. Fresh kidney tissues were mounted using Tissue-Tek O.C.T. Blocks were sectioned into 5 μm-thick slices, washed twice with prepared PBS, and incubated for 30 minutes with DHE (10 μmol/L). The resulting color reaction was immediately measured with a fluorescence microscopy (Leica, Germany).

2.9. Measurement of CSE and CBS and 3-MST Activities

CSE and CBS and 3-MST activities in kidney tissues were measured according to the previous study described [24]. Homogenates from kidney tissues were prepared in ice-cold PBS; after centrifugation at 4°C at 12,000 rpm for 20 minutes, the supernatants were separated for measurement and protein concentrations were quantified by BCA assay. The cofactor pyridoxal-5′-phosphate (2 mmol/L) and enzyme substrate L-cysteine (10 mmol/L) were incorporated to the supernatant; after incubation for 30 minutes, the mixture was used to detect CSE and CBS activity. The α-ketoglutarate (2 mmol/L) and L-cysteine (10 mmol/L) were incorporated to the supernatant; after incubation for 30 minutes, the mixture was used to detect 3-MST activity. The activities of these H2S-generating enzymes were calculated by measuring H2S concentrations in the reaction system and the amount of H2S produced per microgram protein per hour.

2.10. Measurement of H2S Levels

H2S levels in the plasma and kidney tissues were detected according to previously described methods [25]. Homogenates from kidney tissues were prepared using cold Tris-HCl (100 mmol/L, pH 8.5); after centrifugation at 4°C at 12,000 rpm for 20 minutes, the supernatants were separated for measurement and protein concentrations were quantified by BCA assay. 30 μL supernatant or plasma, 80 μL monobromobimane (MBB, Sigma–Aldrich), and 10 μL ammonia (0.1%) were mixed, by shaking at room temperature for 1 h, and 10 μL formic acid (20%) was added to stop the reaction. Following a 10-minute centrifugation (15,000 rpm, 4°C), clear supernatants were frozen at −80°C for detection. H2S levels were determined using a curve formed with sodium sulfide (0–40 μmol/L) standards. Plasma H2S level was expressed as μmol/L, and the H2S level in kidney tissues was expressed as μmol/g of protein.

2.11. Western Blot Analysis

Frozen right kidney specimens were dispersed mechanically in cold RIPA buffer. Proteins in the supernatants were extracted and quantified by BCA assay. After electrophoresis on 10% SDS-PAGE gels, the proteins were blotted to polyvinylidene fluoride (PVDF) membranes (Millipore-Upstate). After blocking in nonfat milk (5%) for 40minutes at room temperature, the membranes were incubated at 4°C for 12–18 hours with antibodies against CSE, CBS, 3-MST, TLR4, NLRP3, caspase-1, and β-actin (CSE and CBS were from Proteintech, USA; 3-MST and TLR4 were obtained from Abcam, USA; NLRP3 was obtained from Abnova, China; and β-actin was obtained from Irvine, USA). After washing three times with TBST, the membranes were incubated with secondary antibodies (Proteintech, USA) at room temperature for 2 h. Blots were detected with an enhanced chemiluminescence detection system (Sage Creation, Beijing, China). Band intensities were quantified using ImageJ software.

2.12. Statistical Analyses

All data analyses were performed using SPSS software version 21.0 (SPSS Inc., Chicago, IL, USA). Results were expressed as the mean ± S.E.M. For a comparison of more than two groups, a one-way analysis of variance (ANOVA), followed by the Student-Newman-Keuls test for multiple comparison, was applied. Comparisons between two groups were assessed by t-test. Statistical significance was defined as a p value of <0.05.

3. Results

3.1. H2S Levels Correlated with Cre and BUN Levels in Patients with SA-AKI

The characteristics of the 10 healthy donors and 10 AKI patients are shown in Table 1. There were no statistically significant differences between the two groups when comparing general features. Compared with controls, plasma Cre (Figure 1(a)) and BUN (Figure 1(b)) levels were significantly higher in patients with SA-AKI, whereas H2S levels were lower (Figure 1(c)). Furthermore, there was a significant inverse correlation between the levels of H2S and Cre (Figure 1(d)) or BUN (Figure 1(e)). This indicated that H2S level decreased during the pathological changes of SA-AKI.

Table 1.

Characteristics of control and SA-AKI patients.

Control (n = 10) AKI (n = 10) p
Age, yrs, mean [SD] 65.3 [8.6] 70.7 [16.0] NS
Gender, male (%) 5 (50) 6 (60) NS
BMI, kg/m2, mean [SD] 24.3 [1.8] 22.7 [2.2] NS
Etiology of sepsis, by organ (n) NA Respiratory (4)
Abdominal (3)
Genitourinary (1)
Intestines (2)
Previous history of chronic kidney disease (yes/no) 0/10 0/10 NS
WBC, ×109/L, mean [SD] 5.4 [1.4] 14.3 [3.1] <0.001
CRP, mg/dL 5.9 [1.5] 41.2 [25.5] 0.002
Open in a new tab

BMI: body mass index; WBC: white blood cell; CRP: C-reactive protein; NS = not significant; NA = not applicable.

Figure 1.

Figure 1

Open in a new tab

H2S levels decreased in patients with SA-AKI. (a) Cre levels in the plasma of control and SA-AKI patients. (b) BUN levels in the plasma of control and SA-AKI patients. (c) H2S levels in the plasma of control and SA-AKI patients. (d) Correlation between H2S and Cre. (e) Correlation between H2S and BUN. (f) TNF-α levels in the plasma of patients. (g) IL-1β levels in the plasma of patients. (h) The activities of MPO in the plasma of patients. (i) The concentrations of H2O2 in the plasma of patients. (j) The concentrations of MDA in the plasma of patients. Results are means ± SEM.

3.2. Inflammatory Cytokine and Oxidative Stress Increased in Patients with SA-AKI

Plasma TNF-α and IL-1β levels increased in the AKI groups compared with those of the controls (Figures 1(f) and 1(g)). Furthermore, MPO activity and plasma H2O2 and MDA concentrations of patients were measured. The results were shown in Figures 1(h)–1(j). MPO activity and H2O2 and MDA concentrations increased in the SA-AKI group compared with those in the control group.

3.3. H2S Played a Role in LPS-Induced AKI

In LPS-induced AKI mice, H2S levels in both the plasma and kidney tissues were significantly lower than those in the control groups (Figures 2(a) and 2(b)). H2S was generated by CBS, CSE, and 3-MST enzymes; therefore, the activity and expression of these three enzymes were measured in the kidney samples. 3-MST activity significantly decreased in the kidney tissues of LPS-induced AKI mice compared with that in controls, but there were no differences in CBS and CSE activities (Figures 2(c) and 2(d)). The expression of 3-MST significantly decreased in LPS-induced AKI mice compared with that in controls, whereas there were no differences in CBS and CSE expression (Figures 2(e)–2(h)). However, treatment with NaHS (50 μmol/kg) significantly increased the LPS-induced reduction of H2S levels in the plasma and kidney tissues (Figures 2(a) and 2(b)), which was accompanied by a decline in plasma Cre and BUN levels (Figures 2(i) and 2(g)). In addition, NaHS treatment significantly ameliorated renal pathological changes caused by LPS. (Figures 2(k) and 2(l)).

Figure 2.

Figure 2

Open in a new tab

H2S levels decreased in mice with LPS-induced AKI, exogenous H2S could attenuate renal dysfunction. (a) H2S levels in plasma. (b) H2S levels in the kidney tissues. (c) 3-MST activity in the kidney tissues. (d) CBS&CSE activity in the kidney tissues. (e) Representative Western blots for 3-MST, CBS, and CSE expression in the kidney tissues. β-Actin was used as the internal control. (f−h) The quantitative analysis for 3-MST, CBS, and CSE expression in the kidney tissues. (i) Cre levels in plasma. (g) BUN levels in plasma. (k) Representative HE-stained right kidney sections (scale bar = 250 μm). (l) Kidney tubular injury score of three groups.

3.4. Exogenous H2S Attenuated Inflammatory Cytokines and Oxidative Stress in Mice with LPS-Induced AKI

Consistent with the performance in SA-AKI patients, plasma TNF-α and IL-1β levels, MPO activity, the ROS levels, and H2O2 and MDA concentrations in the kidney tissues significantly increased in mice with LPS-induced AKI. However, exogenous H2S could significantly attenuate these changes (Figures 3(a)–3(f)).

Figure 3.

Figure 3

Open in a new tab

Exogenous H2S attenuated inflammatory cytokine and oxidative stress in mice with LPS-induced AKI. (a) TNF-α levels in the plasma of mice. (b) IL-1β levels in the plasma of mice. (c) The activity of MPO in the kidney tissue of mice. (d) The ROS levels in the kidney tissue of mice. (e) DHE fluorescence in the kidney tissue of mice. (f) The concentrations of H2O2 in the kidney tissue of mice. (g) The concentrations of MDA in the kidney tissue of mice. Results are means ± SEM.

3.5. Exogenous H2S Attenuated the Formation of NLRP3 in the Kidney Tissues of Mice with LPS-Induced AKI

The exogenous effects of H2S on TLR4, NLRP3, and caspase-1 expressions were detected with Western blot analysis. The expressions of TLR4, NLRP3, and caspase-1 evidently increased in the LPS group compared with those of controls. However, exogenous H2S significantly decreased the protein expressions of TLR4, NLRP3, and caspase-1 (Figure 4).

Figure 4.

Figure 4

Open in a new tab

Exogenous H2S attenuated the formation of inflammasome in mice with LPS-induced AKI. (a) Representative Western blots for TLR4, NLRP3, and caspase-1 expression in the kidney tissues. β-Actin was used as the internal control. (b−d) The quantitative analysis for TLR4, NLRP3, and caspase-1 protein expression in the kidney tissues.

4. Discussion

Numerous studies have shown the protective effects of H2S during diverse pathological processes [16–21]. Our study explored whether renal dysfunction during sepsis correlates with decreased H2S levels and other possible mechanisms. After assessing the results of this study, we found that (1) LPS decreased the level of endogenous H2S and reduced 3-MST activity and expression in the kidney and (2) exogenous supplement of NaHS ameliorated renal dysfunction by inhibiting inflammatory response and oxidative stress through TLR4/NLRP3 signaling pathways. These findings suggested that endogenous H2S contributes to the pathogenesis of SA-AKI, whereas exogenous H2S plays a protective role.

Sepsis is considered to be a systemic inflammatory response syndrome resulting from infection and often occurs in intensive care units. The related multiple organ dysfunction is a leading cause of death in critical patients. The kidney is the most vulnerable organ in sepsis, and mortality of SA-AKI may reach up to 70% [2]. The pathogenesis of SA-AKI is not completely understood. The three major changes that have been recognized in this disease process are inflammation, microcirculatory dysfunction, and cellular metabolic responses to sepsis [26]. LPS induces the release of inflammatory cytokines (especially TNF-α and IL-1β) through TLR4 signaling pathways and contributes to oxidative stress, which can activate tubular epithelial cells and result in functional damage to these cells, subsequently causing renal microcirculatory disturbance and hypoperfusion, which finally leads to SA-AKI [26–28]. The diagnosis of AKI mainly depends on clinical manifestations, urine volume, and blood biochemical markers. Cre and BUN are traditional and critical markers of renal function. MPO is a marker of neutrophil activity, while H2O2 and MDA are common markers of oxidative stress. In this study, we found that Cre and BUN levels, TNF-α and IL-1β levels, MPO activity, and H2O2 and MDA concentrations all significantly increased in the plasma of patients with SA-AKI. The mouse model of LPS-induced AKI was used to simulate the pathogenetic process of AKI, and similar changes were observed in the indicators mentioned above. These data were in agreement with the results of previous studies [6, 7, 10].

As was indicated in various studies, H2S played an essential role in the renal system, in both physiological and pathological status, and H2S levels were decreased in various kidney diseases [15, 20, 21]. To date, three enzymes and four pathways that are involved in the production of H2S have been reported. Kimura's team [14, 29] has demonstrated the formation of H2S from L-cysteine by CBS, CSE, and 3-MST coupled with cysteine aminotransferase (CAT); in addition, 3-MST along with DAO can produce H2S from D-cysteine. Furthermore, they found that the three enzymes are abundant in the kidney, but CBS and CSE are localized in the cytoplasm, whereas 3-MST is mainly found in the mitochondria, and the pathway of H2S production from D-cysteine by 3-MST/DAO only exists in the kidney and brain. To explain the effect of endogenous H2S in the course of SA-AKI, we measured the levels of H2S both in patients and mice with SA-AKI; similar to that demonstrated previously [15, 20], H2S levels significantly decreased and were inversely related to the renal function. To explore the reasons for the decline in H2S levels, we measured the activity of the three enzymes and their expression in the kidney tissues of mice and found that the activity and expression of both CBS and CSE in the kidney did not significantly change after LPS stimulation, but the 3-MST activity significantly decreased; moreover, 3-MST expression was downregulated, which may have contributed to the decrease of H2S. Although experimental studies [20, 21] indicated that protein expressions of CBS and CSE are decreased in kidney dysfunction caused by IRI models, the pathogenesis of SA-AKI is not exactly the same as that of ischemia reperfusion. From Kimura's report [29], we have also found that kidney D-cysteine can produce 60 times more H2S compared with L-cysteine, and D-cysteine is more efficient in protecting renal function. Therefore, we inferred that LPS may affect the H2S production mainly through the D-cysteine/DAO/3-MST pathway, although the mechanisms are still unclear and need further study.

On the basis of the above findings, we evaluated the potential therapeutic utility of exogenous H2S on SA-AKI. NaHS, an H2S donor, was extensively used in various animal models of renal IRI and proven to ameliorate kidney damage [21, 30]. Based on previous studies and preexperimental results, we administered NaHS (50 μmol/kg) 3 h after LPS injection. NaHS had been demonstrated to increase H2S levels in both plasma and kidney tissues of LPS-induced AKI mice and H2S levels close to the normal range. Renal function and histological changes were also improved after NaHS administration, shown by a reduction of Cre and BUN levels in plasma as well as kidney injury score. These results were similar to those of Chen et al. [31], who found that the plasma H2S level is lower in rabbit with SA-AKI derived from the urinary tract, and treatment of NaHS could improve the H2S level, renal function, and pathological changes.

Inflammatory response is a cornerstone in the pathogenesis of SA-AKI. As one of the most important pattern-recognition proteins, TLR4 acts as a major receptor for LPS. Cunningham et al. [8] found that LPS binds to TLR4 in the kidney and induces the release of proinflammatory cytokines, especially TNF-α and IL-1β, which play an essential role during AKI. Fu et al. [32] demonstrated that inhibition of TLR4 could alleviate LPS-induced kidney injury. Meanwhile, Luo et al. [33] have demonstrated that NLRP3 is another important inflammatory regulator in sepsis-induced organ injury. NLRP3 could activate caspase-1, and subsequently, the cleavage and secretion of proinflammatory cytokines (IL-1β and IL-18) are promoted. Alfonso-Loeches et al. [34] showed the crosstalk between TLR4 and NLRP3 and found that activation of NLRP3 and secretion of inflammatory cytokines mostly disappeared in chronic alcohol-fed TLR4 knockout mice, which suggested that NLRP3 activation depends on TLR4 function. Over the years, various studies have shown the key role of H2S as a mediator of inflammation in various clinical settings. Shibuya et al. [15] demonstrated that H2S suppressed high glucose-induced cardiomyocyte inflammation by inhibiting the TLR4/NF-κB pathway and NLRP3 activation. Moreover, Tan et al. [35] also identified the protective effect of endogenous H2S on renal IRI by suppressing inflammatory response through the inhibition of the TLR pathway. Zhang et al. [19] demonstrated that H2S could attenuate LPS-induced acute lung injury by reducing oxidative stress and inhibiting inflammation. Similar findings have been reported by Li et al. [36], who tested the role of H2S in mice with acute lung injury and found that exogenous H2S reduced lung permeability by suppressing oxidative stress and inflammation. Chen et al. [31] revealed that by inhibiting NF-κB, H2S was able to decrease the plasma level of TNF-α and increase IL-10 level. To investigate the anti-inflammatory mechanism of H2S, we observed the effects of H2S on TLR4/NLRP3 signaling pathway and found that LPS could increase TLR4, NLRP3, and caspase-1 expression in kidney tissues, accompanied by plasma elevation of downstream inflammatory factors (TNF-α and IL-1β) and oxidative stress markers (MPO, H2O2, and MDA). In addition, our results showed that treatment with NaHS at 50 μmol/kg could protect renal function by suppressing the release of inflammatory cytokines and oxidative stress, as well as TLR4, NLRP3, and caspase-1 expression.

5. Conclusion

In conclusion, our study suggested that endogenous H2S is involved in the pathogenesis of SA-AKI, and exogenous H2S exerts protective effects by inhibiting inflammation and oxidative stress via the TLR4/NLRP3 signaling pathway. These findings will shed light on the role of H2S as a therapeutic agent for renal diseases.

Acknowledgments

This study was supported by the National Natural Science Foundation of China (Grant nos. 31171098, 30400513, and 31671185), the Natural Science Foundation of Hebei Province of China (H2017206269), the Specialized Research Fund for the Doctoral Program of Higher Education of China (no. 20121323110008), the Hebei Province for Innovation Talents Support Plan (Grant LJRC017), and the Office of Education Foundation of Hebei Province of China (QN2016144).

Conflicts of Interest

The authors declare that there are no conflicts of interests regarding the publication of this paper.

Authors' Contributions

Yuhong Chen and Sheng Jin contributed equally to this work.

References

  • 1.Hoste E. A., Bagshaw S. M., Bellomo R., et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Medicine. 2015;41(8):1411–1423. doi: 10.1007/s00134-015-3934-7. [DOI] [PubMed] [Google Scholar]
  • 2.Uchino S., Kellum J. A., Bellomo R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813–818. doi: 10.1001/jama.294.7.813. [DOI] [PubMed] [Google Scholar]
  • 3.Shum H.-P., Yan W.-W., Chan T. M. Recent knowledge on the pathophysiology of septic acute kidney injury: a narrative review. Journal of Critical Care. 2016;31(1):82–89. doi: 10.1016/j.jcrc.2015.09.017. [DOI] [PubMed] [Google Scholar]
  • 4.Bellomo R., Kellum J. A., Ronco C., et al. Acute kidney injury in sepsis. Intensive Care Medicine. 2017;43(6):816–828. doi: 10.1007/s00134-017-4755-7. [DOI] [PubMed] [Google Scholar]
  • 5.Kim D. H., JJ Y., Lee A. S., et al. COMP-angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney International. 2009;76(11):1180–1191. doi: 10.1038/ki.2009.387. [DOI] [PubMed] [Google Scholar]
  • 6.Zarjou A., Agarwal A. Sepsis and acute kidney injury. Journal of the American Society of Nephrology. 2011;22(6):999–1006. doi: 10.1681/ASN.2010050484. [DOI] [PubMed] [Google Scholar]
  • 7.Wang H., Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. The American Journal of Emergency Medicine. 2008;26(6):711–715. doi: 10.1016/j.ajem.2007.10.031. [DOI] [PubMed] [Google Scholar]
  • 8.Cunningham P. N., Wang Y., Guo R., He G., Quigg R. J. Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. The Journal of Immunology. 2004;172(4):2629–2635. doi: 10.4049/jimmunol.172.4.2629. [DOI] [PubMed] [Google Scholar]
  • 9.Takeda K., Akira S. Toll-like receptors in innate immunity. International Immunology. 2005;17(1):1–14. doi: 10.1093/intimm/dxh186. [DOI] [PubMed] [Google Scholar]
  • 10.Byun E. B., Sung N. Y., Park J. N., Yang M. S., Park S. H., Byun E. H. Gamma-irradiated resveratrol negatively regulates LPS-induced MAPK and NF-κB signaling through TLR4 in macrophages. International Immunopharmacology. 2015;25(2):249–259. doi: 10.1016/j.intimp.2015.02.015. [DOI] [PubMed] [Google Scholar]
  • 11.Abderrazak A., Syrovets T., Couchie D., et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases. Redox Biology. 2015;4:296–307. doi: 10.1016/j.redox.2015.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bauernfeind F. G., Horvath G., Stutz A., et al. Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. The Journal of Immunology. 2009;183(2):787–791. doi: 10.4049/jimmunol.0901363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Warenycia M. W., Goodwin L. R., Benishin C. G., et al. Acute hydrogen sulfide poisoning: demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels. Biochemical Pharmacology. 1989;38:973–981. doi: 10.1016/0006-2952(89)90288-8. [DOI] [PubMed] [Google Scholar]
  • 14.Kimura H. Hydrogen sulfide: its production, release and functions. Amino Acids. 2011;41(1):113–121. doi: 10.1007/s00726-010-0510-x. [DOI] [PubMed] [Google Scholar]
  • 15.Shibuya N., Koike S., Tanaka M., Ishigami-Yuasa M., Kimura Y., Ogasawara Y. A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nature Communications. 2013;4:p. 1366. doi: 10.1038/ncomms2371. [DOI] [PubMed] [Google Scholar]
  • 16.Huang Z., Zhuang X., Xie C., et al. Exogenous hydrogen sulfide attenuates high glucose-induced cardiotoxicity by inhibiting NLRP3 inflammasome activation by suppressing TLR4/NF-κB pathway in H9C2 cells. Cellular Physiology and Biochemistry. 2016;40(6):1578–1590. doi: 10.1159/000453208. [DOI] [PubMed] [Google Scholar]
  • 17.Avanzato D., Merlino A., Porrera S., Wang R., Munaron L., Mancardi D. Role of calcium channels in the protective effect of hydrogen sulfide in rat cardiomyoblasts. Cellular Physiology and Biochemistry. 2014;33(4):1205–1214. doi: 10.1159/000358690. [DOI] [PubMed] [Google Scholar]
  • 18.Yu Q., Lu Z., Tao L., et al. ROS-dependent neuroprotective effects of NaHS in ischemia brain injury involves the PARP/AIF pathway. Cellular Physiology and Biochemistry. 2015;36(4):1539–1551. doi: 10.1159/000430317. [DOI] [PubMed] [Google Scholar]
  • 19.Zhang H. X., Liu S. J., Tang X. L., et al. H2S attenuates LPS-induced acute lung injury by reducing oxidative/nitrative stress and inflammation. Cellular Physiology and Biochemistry. 2016;40(6):1603–1612. doi: 10.1159/000453210. [DOI] [PubMed] [Google Scholar]
  • 20.Ahmad A., Olah G., Szczesny B., Wood M. E., Whiteman M., Szabo C. AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in vitro and in acute renal injury in vivo. Shock. 2015;45(1):88–97. doi: 10.1097/SHK.0000000000000478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Han S. J., Kim J. I., Park J. W., Park K. M. Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury. Nephrology Dialysis Transplantation. 2015;30:1497–1506. doi: 10.1093/ndt/gfv226. [DOI] [PubMed] [Google Scholar]
  • 22.KDIGO AKI Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012;2:1–138. [Google Scholar]
  • 23.Leelahavanichkul A., Yasuda H., Doi K., et al. Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice. American Journal of Physiology - Renal Physiology. 2008;295(6):F1825–F1835. doi: 10.1152/ajprenal.90442.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tao B. B., Liu S. Y., Zhang C. C., et al. VEGFR2 functions as an H2S-targeting receptor protein kinase with its novel Cys1045–Cys1024 disulfide bond serving as a specific molecular switch for hydrogen sulfide actions in vascular endothelial cells. Antioxidants & Redox Signaling. 2013;19(5):448–464. doi: 10.1089/ars.2012.4565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Jin S., Pu S. X., Hou C. L., et al. Cardiac H2S generation is reduced in ageing diabetic mice. Oxidative Medicine and Cellular Longevity. 2015;2015:14. doi: 10.1155/2015/758358.758358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gomez H., Kellum J. A. Sepsis-induced acute kidney injury. Current Opinion in Critical Care. 2016;22(6):546–553. doi: 10.1097/MCC.0000000000000356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Seely K. A., Holthoff J. H., Burns S. T. Hemodynamic changes in the kidney in a pediatric rat model of sepsis-induced acute kidney injury. American Journal of Physiology - Renal Physiology. 2011;301(1):F209–F217. doi: 10.1152/ajprenal.00687.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Grigoryev D. N., Liu M., Hassoun H. T., Cheadle C., Barnes K. C., Rabb H. The local and systemic inflammatory transcriptome after acute kidney injury. Journal of the American Society of Nephrology. 2008;19(3):547–558. doi: 10.1681/ASN.2007040469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kimura H. Physiological role of hydrogen sulfide and polysulfide in the central nervous system. Neurochemistry International. 2013;63(5):492–497. doi: 10.1016/j.neuint.2013.09.003. [DOI] [PubMed] [Google Scholar]
  • 30.Azizi F., Seifi B., Kadkhodaee M., Ahghari P. Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. Irish Journal of Medical Science. 2015;185(3):649–654. doi: 10.1007/s11845-015-1328-z. [DOI] [PubMed] [Google Scholar]
  • 31.Chen X., Xu W., Wang Y., et al. Hydrogen sulfide reduces kidney injury due to urinary-derived sepsis by inhibiting NF-κB expression, decreasing TNF-α levels and increasing IL-10 levels. Experimental and Therapeutic Medicine. 2014;8(2):464–470. doi: 10.3892/etm.2014.1781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fu H., Hu Z., Di X., Zhang Q., Zhou R., Du H. Tenuigenin exhibits protective effects against LPS-induced acute kidney injury via inhibiting TLR4/NF-κB signaling pathway. European Journal of Pharmacology. 2016;791:229–234. doi: 10.1016/j.ejphar.2016.08.013. [DOI] [PubMed] [Google Scholar]
  • 33.Luo Y. P., Jiang L., Kang K., et al. Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1. International Immunopharmacology. 2014;20(1):24–32. doi: 10.1016/j.intimp.2014.02.017. [DOI] [PubMed] [Google Scholar]
  • 34.Alfonso-Loeches S., Urena-Peralta J., Morillo-Bargues M. J., Morillo-Bargues J., Gómez-Pinedo U., Guerri C. Ethanol-induced TLR4/NLRP3 neuroinflammatory response in microglial cells promotes leukocyte infiltration across the BBB. Neurochemical Research. 2015;41(1-2):193–209. doi: 10.1007/s11064-015-1760-5. [DOI] [PubMed] [Google Scholar]
  • 35.Tan Z., Shi Y., Yan Y., Liu W., Li G., Li R. Impact of endogenous hydrogen sulfide on toll-like receptor pathway in renal ischemia/reperfusion injury in rats. Renal Failure. 2015;37(4):727–733. doi: 10.3109/0886022X.2015.1012983. [DOI] [PubMed] [Google Scholar]
  • 36.Li H. D., Zhang Z. R., Zhang Q. X., Qin Z. C., He D. M., Chen J. S. Treatment with exogenous hydrogen sulfide attenuates hyperoxia-induced acute lung injury in mice. European Journal of Applied Physiology. 2013;113(6):1555–1563. doi: 10.1007/s00421-012-2584-5. [DOI] [PubMed] [Google Scholar]

Articles from Oxidative Medicine and Cellular Longevity are provided here courtesy of Wiley

RESOURCES